The funds raised by this purchase will be used in part to finance Asterias' therapeutic product development programs, which are based on the potential of using human embryonic stem cells to create innovative new therapies for diseases and conditions for which effective treatments are not presently available .
http://ift.tt/1o5mRpD
http://ift.tt/1o5mRpD
No comments:
Post a Comment